Aridis Pharmaceuticals Says On March 10 Co. Received Notice From Nasdaq Indicating Bid Price For Co.'s Common Stock For Last 30 Consecutive Business Days Had Closed Below Minimum $1.00/Share
Aridis Pharmaceuticals Says On March 10 Co. Received Notice From Nasdaq Indicating Bid Price For Co.'s Common Stock For Last 30 Consecutive Business Days Had Closed Below Minimum $1.00/Share
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.